Home
ADAR1 Capital Management, 10% Owner: Palvella Therapeutics PVLA Buy · Filed 24/08/12
Trade details
- Type
- Insider buy
- Amount
- $44,670
- Shares · price
- 3,000 sh · $14.89 a share
- Held after
- 127,331 sh
- Trade date
- 24/08/09
- Filed
- 24/08/12
- Days to filing
- 3 days
First buy since 2023
- Insiders buying this week
- 3 insiders
- Holding change
- +2.4%
Palvella Therapeutics trades, last 26 weeks
What else happened in Palvella Therapeutics around then
Filed or reported within 30 days of the trade day · 24/07/10~24/09/08ADAR1 Capital Management's recent trades
- ADAR1 Capital Management
BuyInMed Pharmaceuticals
BuyInMed Pharmaceuticals
INM
$312K
200,000 sh
$312K
Filed 05/21
Traded 05/19
- ADAR1 Capital Management
BuyInMed Pharmaceuticals
BuyInMed Pharmaceuticals
INM
$300K
200,000 sh
$300K
Filed 05/21
Traded 05/19
- ADAR1 Capital Management
BuyInMed Pharmaceuticals
BuyInMed Pharmaceuticals
INM
$109.7K
68,551 sh
$109.7K
Filed 05/21
Traded 05/19
- ADAR1 Capital Management
BuyRallybio
BuyRallybio
RLYB
$139.8K
10,000 sh
$139.8K
Filed 05/20
Traded 05/19
- ADAR1 Capital Management
BuyRallybio
BuyRallybio
RLYB
$84K
6,009 sh
$84K
Filed 05/20
Traded 05/18